Publications by authors named "Bharathi Mandala"

Claim this Profile
N
Nanotechnology Platform for the Delivery of Docetaxel and Tyrosine Kinase Inhibitors for HER2-Positive Breast Cancer Therapy.
Bharathi Mandala, Yvonne Berko, Gantumur Battogtokh, Funmilola Fisusi, Haijun Gao

Pharm Nanotechnol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Neratinib and Docetaxel Core-Loaded and Trastuzumab Surface-Conjugated Nanoparticle for Treatment of HER-2 Positive Breast Cancer.
Victor Ejigah, Gantumur Battogtokh, Bharathi Mandala, Emmanuel O Akala

Pharmaceutics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanotechnology in the development of small and large molecule tyrosine kinase inhibitors and immunotherapy for the treatment of HER2-positive breast cancer.
Victor Ejigah, Bharathi Mandala, Emmanuel O Akala

J Cancer Metastasis Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis